PSDVProcess Shut Down Valve (oil & gas)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
(NASDAQ: PSDV) (ASX: PVA) (FF: PV3), Watertown, Mass., a drug delivery company with two of the only three ophthalmic sustained release delivery products approved by the FDA for treatment of back of the eye diseases, has announced financial results for its fourth quarter and fiscal year ended June 30, 2009.
The former ticker symbol "PSDV" will remain effective through the market close on March 29.
(NASDAQ: PSDV) (ASX: PVA) has completed the originally targeted enrollment of 120 patients in its pivotal Phase III clinical trial of its Medidur for the treatment of posterior uveitis, the company said on Thursday.